Drug Therapy, Combination

Experimental Therapeutics
Effects of Antibiotic Therapy on Pseudomonas aeruginosa-Induced Lung Injury in a Rat Model
Erika J. Ernst, Satoru Hashimoto, Joseph Guglielmo, Teiji Sawa, Jean-Francois Pittet, Helmut Kropp, Jesse J. Jackson, Jeanine P. Wiener-Kronish
Pharmacology
Use of Pharmacodynamic Indices To Predict Efficacy of Combination Therapy In Vivo
Johan W. Mouton, Marc L. van Ogtrop, David Andes, William A. Craig
Experimental Therapeutics
Treatment of Experimental Staphylococcal Endocarditis Due to a Strain with Reduced Susceptibility In Vitro to Vancomycin: Efficacy of Ampicillin-Sulbactam
Mirjana Backo, Eliza Gaenger, Anna Burkart, Yin Li Chai, Arnold S. Bayer
Experimental Therapeutics
Comparative Efficacies of Liposomal Amikacin (MiKasome) plus Oxacillin versus Conventional Amikacin plus Oxacillin in Experimental Endocarditis Induced by Staphylococcus aureus: Microbiological and Echocardiographic Analyses
Yan-Qiong Xiong, Leon Iri Kupferwasser, Philip M. Zack, Arnold S. Bayer
Experimental Therapeutics
Combinations of Vancomycin and β-Lactams Are Synergistic against Staphylococci with Reduced Susceptibilities to Vancomycin
Michael W. Climo, Roberto L. Patron, Gordon L. Archer
Susceptibility
In Vitro Susceptibilities of Chlamydia pneumoniae Isolates from German Patients and Synergistic Activity of Antibiotic Combinations
Heike M. Freidank, Philipp Losch, Heike Vögele, Margit Wiedmann-Al-Ahmad
Experimental Therapeutics
In Vivo Efficacies of Combinations of β-Lactams, β-Lactamase Inhibitors, and Rifampin against Acinetobacter baumannii in a Mouse Pneumonia Model
Michel Wolff, Marie-Laure Joly-Guillou, Robert Farinotti, Claude Carbon
Pharmacology
Piperacillin and Tazobactam Exhibit Linear Pharmacokinetics after Multiple Standard Clinical Doses
Barbara Auclair, Murray P. Ducharme
Experimental Therapeutics
Effect of Azithromycin plus Rifampin versus That of Azithromycin Alone on the Eradication of Chlamydia pneumoniae from Lung Tissue in Experimental Pneumonitis
Katerina Wolf, Raffaele Malinverni
Pharmacology
Pharmacokinetics and Pharmacodynamics of Amoxicillin-Sulbactam, a Novel Aminopenicillin–β-Lactamase Inhibitor Combination, against Escherichia coli
Carlos Bantar, Federico Nicola, Hector J. Arenoso, Marcelo Galas, Liliana Soria, Diego Dana, Alicia Rossi, Hebe Bianchini, Abel Jasovich

Pages